Thousands of heartburn patients to be tracked for years in major new study
NCT ID NCT03853772
First seen Jun 27, 2026 · Last updated Aug 27, 2026 · Updated 2 times
Summary
This study is creating a large registry of 2,000 people with gastroesophageal reflux disease (GERD) and related conditions like Barrett's esophagus. Researchers will collect data from medical records and questionnaires over 5 years to better understand the disease and its treatments. The goal is to gather information, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 2,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2019
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients referred by physicians having diagnostic evaluation or treatment for GERD.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Referred GERD patients willing to participate in long term follow-up (5 years) Exclusion Criteria: * Potential participants will be excluded if unwilling or unable to complete surveillance questionnaires through this registry
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Barrett esophagus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
9 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Fox Valley Surgical Associates
Appleton, Wisconsin, 54911, United States
-
Geisinger
Danville, Pennsylvania, 17822, United States
-
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
The Matagorda Regional Medical Group
Bay City, Texas, 77414, United States
-
UCI-Irvine
Orange, California, 92868, United States
-
UNRMed-University of Nevada, Reno
Reno, Nevada, 89557, United States
-
UT Health
Houston, Texas, 77030, United States
-
Weill Cornell
New York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Swallowable capsule and lab test take on endoscopy for esophageal cancer screening
- What do patients really want when facing oesophageal cancer surgery?
- Can a radiofrequency zap calm stubborn heartburn?
- Can a Pre-Surgery checklist predict who will still have reflux after fundoplication?
- Can thread acupuncture boost GERD relief beyond standard pills?
- New acid blocker may offer stronger reflux control for Barrett's esophagus